Search for: "PFIZER"
Results 3301 - 3320
of 4,635
Sort by Relevance
|
Sort by Date
8 Jan 2010, 5:00 am
After the Pfizer decision was handed down in 2006, however, the defendant moved to decertify the classes. [read post]
7 Jan 2010, 4:40 pm
” Plaintiffs’ attorney Tobias Millrood, “winner of a $34 million verdict against Pfizer,” said, “It’s a reflection of the fact that Main Street is hurting. [read post]
7 Jan 2010, 1:32 pm
In the case at hand, Dentsply's motion for decertification was accompanied by changed circumstances, most notably the Pfizer decision. [read post]
7 Jan 2010, 11:16 am
In turn, patent law has impacted on the life science industries. ... the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. [read post]
7 Jan 2010, 10:54 am
Subsequent to the Second District’s decision in Pfizer, Dentsply moved to decertify the UCL claim based on Pfizer’s conclusion that Prop 64 standing extended to members of the class. [read post]
7 Jan 2010, 10:36 am
Remember Gresham’s law? [read post]
6 Jan 2010, 6:18 pm
If so, head over to GoInhouse.com to check out the latest postings - here are a few companies that could be looking for you: Sr Corporate Counsel, Research - Pfizer Inc., La Jolla, CA Sr Corporate Counsel, Global Privacy Office - Pfizer Inc., New York, NY Lead Counsel, Southeast Regional Business Unit - Pfizer Inc., Atlanta, GA Global Specialty Care Product Counsel - Pfizer Inc., Collegeville, AL R&D Regulatory Law & Compliance Counsel - Pfizer… [read post]
6 Jan 2010, 3:32 am
(Patent Docs) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaints against Pliva Hrvatska and Teva following Para IV challenge (Patent Docs) (Patent Docs) (IP Factor) Emend (Fosaprepitant dimeglumine) – US: FDA issues exclusivity decision for Merck’s Emend; Agency reverses course and grants NCE exclusivity (FDA Law Blog) Gemzar (Gemcitabine) – US: Eli Lilly in new patent fight for chemotherapy drug (GenericsWeb) Humira… [read post]
5 Jan 2010, 7:16 pm
New York-based Pfizer, the world’s largest drugmaker, completed its purchase of Wyeth in October. [read post]
5 Jan 2010, 5:37 am
Pfizer argues that Plaintiff should have been a better physician (or a better prognosticator?) [read post]
4 Jan 2010, 7:04 pm
Pfizer does not agree that studies have shown that the drugs cause breast cancer. [read post]
4 Jan 2010, 2:22 pm
Cheryl Hall wrote an interesting article yesterday that appeared in the Dallas Morning News. [read post]
4 Jan 2010, 1:50 pm
In fact, Pfizer -- the pharmaceutical company that now owns Wyeth -- has lost six of nine jury verdicts over its menopause drugs since the cases began going to trial in 2006. [read post]
4 Jan 2010, 8:38 am
Move on for a bit, would you Pfizer? [read post]
4 Jan 2010, 7:33 am
"Pfizer Must Face Menopause-Drug Award, Court Finds": Jef Feeley of Bloomberg News has this report on last Thursday's ruling of the Superior Court of Pennsylvania. [read post]
4 Jan 2010, 5:19 am
On Dec. 21 and Dec. 22 New York courts declined to hear two lawsuits -- on an Austrian train wreck and Pfizer's Lipitor -- that should more properly have been filed elsewhere. [read post]
31 Dec 2009, 11:46 am
Pfizer Hospital Products Group, Inc., 872 S.W.2d 908, 911-12 (Tenn. [read post]
31 Dec 2009, 7:19 am
In October, the FTC conditionally approved Pfizer, Inc. [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
